Steven B. McMahon - Publications

Affiliations: 
University of Pennsylvania, Philadelphia, PA, United States 
Area:
Molecular Biology, Cell Biology

72 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Stanek TJ, Gennaro VJ, Tracewell MA, Di Marcantonio D, Pauley KL, Butt S, McNair C, Wang F, Kossenkov AV, Knudsen KE, Butt T, Sykes SM, McMahon SB. The SAGA complex regulates early steps in transcription via its deubiquitylase module subunit USP22. The Embo Journal. e102509. PMID 34155658 DOI: 10.15252/embj.2019102509  0.653
2021 Farkas M, McMahon S. Unlocking p53 response elements: DNA shape is the key. Molecular & Cellular Oncology. 8: 1905489. PMID 34027043 DOI: 10.1080/23723556.2021.1905489  0.307
2021 Farkas M, Hashimoto H, Bi Y, Davuluri RV, Resnick-Silverman L, Manfredi JJ, Debler EW, McMahon SB. Distinct mechanisms control genome recognition by p53 at its target genes linked to different cell fates. Nature Communications. 12: 484. PMID 33473123 DOI: 10.1038/s41467-020-20783-z  0.321
2019 McCann JJ, Vasilevskaya IA, Poudel Neupane N, Shafi AA, McNair C, Dylgjeri E, Mandigo AC, Schiewer MJ, Schrecengost RS, Gallagher P, Stanek TJ, McMahon SB, Berman-Booty LD, Ostrander WF, Knudsen KE. USP22 functions as an oncogenic driver in prostate cancer by regulating cell proliferation and DNA repair. Cancer Research. PMID 31740444 DOI: 10.1158/0008-5472.Can-19-1033  0.46
2019 Farkas M, McMahon SB. Rapid Detection of p53 Acetylation Status in Response to Cellular Stress Signaling. Methods in Molecular Biology (Clifton, N.J.). 1983: 255-262. PMID 31087303 DOI: 10.1007/978-1-4939-9434-2_15  0.439
2019 Barta JA, Pauley K, Kossenkov AV, McMahon SB. The lung-enriched p53 mutants V157F and R158L/P regulate a gain of function transcriptome in lung cancer. Carcinogenesis. PMID 31067569 DOI: 10.1093/Carcin/Bgz087  0.4
2019 Gennaro VJ, Wedegaertner H, McMahon SB. Interaction between the BAG1S isoform and HSP70 mediates the stability of anti-apoptotic proteins and the survival of osteosarcoma cells expressing oncogenic MYC. Bmc Cancer. 19: 258. PMID 30902071 DOI: 10.1186/S12885-019-5454-2  0.455
2018 Barta JA, McMahon SB. Lung-enriched Mutations in the p53 Tumor Suppressor: A Paradigm for Tissue-specific Gain of Oncogenic Function. Molecular Cancer Research : McR. PMID 30224539 DOI: 10.1158/1541-7786.Mcr-18-0357  0.331
2018 Gennaro VJ, Stanek TJ, Peck AR, Sun Y, Wang F, Qie S, Knudsen KE, Rui H, Butt T, Diehl JA, McMahon SB. Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 30224477 DOI: 10.1073/Pnas.1807704115  0.443
2018 Barta JA, McMahon SB. Abstract A25: Urokinase plasminogen activator expression is regulated by p53 harboring the lung cancer-specific mutation V157F Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Aacriaslc18-A25  0.418
2018 Butt S, Stanek TJ, Gennaro VJ, McNair C, Pauley KL, Knudsen K, McMahon SB. Abstract LB-A29: Divergent mechanisms of transcriptional regulation by SAGA member and epigenetic modifier USP22 Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-Lb-A29  0.485
2017 Bu Y, Yoshida A, Chitnis N, Altman BJ, Tameire F, Oran A, Gennaro V, Armeson KE, McMahon SB, Wertheim GB, Dang CV, Ruggero D, Koumenis C, Fuchs SY, Diehl JA. A PERK-miR-211 axis suppresses circadian regulators and protein synthesis to promote cancer cell survival. Nature Cell Biology. PMID 29230015 DOI: 10.1038/S41556-017-0006-Y  0.39
2017 Petruk S, Cai J, Sussman R, Sun G, Kovermann SK, Mariani SA, Calabretta B, McMahon SB, Brock HW, Iacovitti L, Mazo A. Delayed Accumulation of H3K27me3 on Nascent DNA Is Essential for Recruitment of Transcription Factors at Early Stages of Stem Cell Differentiation. Molecular Cell. PMID 28410996 DOI: 10.1016/J.Molcel.2017.03.006  0.411
2016 Cheng, Zhao Y, Wang S, Zhang F, Russo M, McMahon SB, Zhu J. Repression of telomerase gene promoter requires human-specific genomic context and is mediated by multiple HDAC1-containing corepressor complexes. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 27940549 DOI: 10.1096/Fj.201601111R  0.414
2016 Oran AR, Adams CM, Zhang XY, Gennaro VJ, Pfeiffer HK, Mellert HS, Seidel HE, Mascioli K, Kaplan J, Gaballa MR, Shen C, Rigoutsos I, King MP, Cotney JL, Arnold JJ, ... ... McMahon SB, et al. Multi-focal control of mitochondrial gene expression by oncogenic MYC provides potential therapeutic targets in cancer. Oncotarget. PMID 27590350 DOI: 10.18632/Oncotarget.11718  0.737
2016 Monteith JA, Mellert H, Sammons MA, Kuswanto LA, Sykes SM, Resnick-Silverman L, Manfredi JJ, Berger SL, McMahon SB. A rare DNA contact mutation in cancer confers p53 gain-of-function and tumor cell survival via TNFAIP8 induction. Molecular Oncology. PMID 27341992 DOI: 10.1016/J.Molonc.2016.05.007  0.788
2016 Gennaro V, Zhang X, DeSalle L, Yu D, Thomas-Tikhonenko A, Vakoc C, McMahon SB. Abstract 4553: Identification of CD30/TNFRSF8 as a primary target of the Myc oncoprotein and potential biomarker of Myc-driven cancer Cancer Research. 76: 4553-4553. DOI: 10.1158/1538-7445.Am2016-4553  0.375
2016 Taylor A, Adams C, Zhang X, Gennaro V, Cotney J, Shadel G, Cameron C, Eischen C, McMahon S. Abstract 1256: Multi-focal control of mitochondrial gene expression by oncogenic MYC provides effective therapeutic targets in cancer Cancer Research. 76: 1256-1256. DOI: 10.1158/1538-7445.Am2016-1256  0.441
2015 Tutton S, Azzam GA, Stong N, Vladimirova O, Wiedmer A, Monteith JA, Beishline K, Wang Z, Deng Z, Riethman H, McMahon SB, Murphy M, Lieberman PM. Subtelomeric p53 binding prevents accumulation of DNA damage at human telomeres. The Embo Journal. PMID 26658110 DOI: 10.15252/Embj.201490880  0.434
2015 Gennaro V, Zhang X, DeSalle L, Yu D, Thomas-Tikhonenko A, McMahon S. Abstract A40: CD30: A therapeutic target of MYC-driven cancer Molecular Cancer Research. 13. DOI: 10.1158/1557-3125.Myc15-A40  0.361
2015 Taylor A, Zhang X, Cotney J, Shadel G, Cameron C, McMahon S. Abstract A05: The mitochondrial RNA polymerase is an essential downstream effector of the MYC oncoprotein Molecular Cancer Research. 13. DOI: 10.1158/1557-3125.Myc15-A05  0.436
2015 Wang F, Stanek TR, Biswas L, Kodrasov M, LaRocque J, Wu J, Sterner D, Weinstock J, Mattern M, McMahon SB, Kumar S. Abstract 5432: Discovery and characterization of USP22 inhibitors as novel anti-cancer agents Cancer Research. 75: 5432-5432. DOI: 10.1158/1538-7445.Am2015-5432  0.449
2014 McMahon SB. MYC and the control of apoptosis. Cold Spring Harbor Perspectives in Medicine. 4: a014407. PMID 24985130 DOI: 10.1101/Cshperspect.A014407  0.429
2014 Yanagisawa J, Kitagawa H, Yanagida M, Wada O, Ogawa S, Nakagomi M, Oishi H, Yamamoto Y, Nagasawa H, McMahon SB, Cole MD, Tora L, Takahashi N, Kato S. Retraction Notice to: Nuclear receptor function requires a TFTC-type histone acetyl transferase complex Molecular Cell. 54: 536. PMID 24932468 DOI: 10.1016/J.Molcel.2014.04.017  0.302
2014 Schrecengost RS, Dean JL, Goodwin JF, Schiewer MJ, Urban MW, Stanek TJ, Sussman RT, Hicks JL, Birbe RC, Draganova-Tacheva RA, Visakorpi T, DeMarzo AM, McMahon SB, Knudsen KE. USP22 regulates oncogenic signaling pathways to drive lethal cancer progression. Cancer Research. 74: 272-86. PMID 24197134 DOI: 10.1158/0008-5472.Can-13-1954  0.39
2013 Monteith J, McMahon SB. p53: the TRiC is knowing when to fold 'em. Molecular Cell. 50: 781-2. PMID 23806333 DOI: 10.1016/J.Molcel.2013.06.009  0.387
2013 Chen K, Wu K, Gormley M, Ertel A, Wang J, Zhang W, Zhou J, Disante G, Li Z, Rui H, Quong AA, McMahon SB, Deng H, Lisanti MP, Wang C, et al. Acetylation of the cell-fate factor dachshund determines p53 binding and signaling modules in breast cancer. Oncotarget. 4: 923-35. PMID 23798621 DOI: 10.18632/Oncotarget.1094  0.395
2013 Sussman RT, Stanek TJ, Esteso P, Gearhart JD, Knudsen KE, McMahon SB. The epigenetic modifier ubiquitin-specific protease 22 (USP22) regulates embryonic stem cell differentiation via transcriptional repression of sex-determining region Y-box 2 (SOX2). The Journal of Biological Chemistry. 288: 24234-46. PMID 23760504 DOI: 10.1074/Jbc.M113.469783  0.369
2013 Chen K, Wu K, Cai S, Zhang W, Zhou J, Wang J, Ertel A, Li Z, Rui H, Quong A, Lisanti MP, Tozeren A, Tanes C, Addya S, Gormley M, ... ... McMahon SB, et al. Dachshund binds p53 to block the growth of lung adenocarcinoma cells. Cancer Research. 73: 3262-74. PMID 23492369 DOI: 10.1158/0008-5472.Can-12-3191  0.405
2013 Armour SM, Bennett EJ, Braun CR, Zhang XY, McMahon SB, Gygi SP, Harper JW, Sinclair DA. A high-confidence interaction map identifies SIRT1 as a mediator of acetylation of USP22 and the SAGA coactivator complex. Molecular and Cellular Biology. 33: 1487-502. PMID 23382074 DOI: 10.1128/Mcb.00971-12  0.387
2013 Pestell R, Chen K, Wu K, Gormley M, Ertel A, Zhang W, Zhou J, DiSante G, Li Z, Rui H, Quong A, McMahon S, Deng H, Lisanti M, Wang C. Abstract P5-11-04: Post-translational modification of the cell-fate factor Dachshund determines p53 binding and signaling modules in breast cancer Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P5-11-04  0.432
2012 Den RB, Ciment S, Sharma A, Mellert H, McMahon S, Dicker A, Knudsen KE. Differential response of prostate cancer cells to ionizing radiation: The RB status. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 106. PMID 27968000 DOI: 10.1200/Jco.2012.30.5_Suppl.106  0.713
2012 Blomain ES, McMahon SB. Dynamic regulation of mitochondrial transcription as a mechanism of cellular adaptation. Biochimica Et Biophysica Acta. 1819: 1075-9. PMID 22766037 DOI: 10.1016/J.Bbagrm.2012.06.004  0.373
2012 Yuan H, Rossetto D, Mellert H, Dang W, Srinivasan M, Johnson J, Hodawadekar S, Ding EC, Speicher K, Abshiru N, Perry R, Wu J, Yang C, Zheng YG, Speicher DW, ... ... McMahon SB, et al. MYST protein acetyltransferase activity requires active site lysine autoacetylation. The Embo Journal. 31: 58-70. PMID 22020126 DOI: 10.1038/Emboj.2011.382  0.727
2012 Chen K, Wu K, Zhang W, Zhou J, Stanek T, Li Z, Wang C, Shirley LA, Rui H, Mcmahon S, Pestell RG. Abstract LB-144: A p53-dependent G2/M checkpoint governed by the cell-fate factor dachshund in non-small cell lung cancer Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-144  0.436
2011 Zhang XY, Pfeiffer HK, Mellert HS, Stanek TJ, Sussman RT, Kumari A, Yu D, Rigoutsos I, Thomas-Tikhonenko A, Seidel HE, Chodosh LA, Packham G, Baserga R, McMahon SB. Inhibition of the single downstream target BAG1 activates the latent apoptotic potential of MYC. Molecular and Cellular Biology. 31: 5037-45. PMID 21986497 DOI: 10.1128/Mcb.06297-11  0.775
2011 Charvet C, Wissler M, Brauns-Schubert P, Wang SJ, Tang Y, Sigloch FC, Mellert H, Brandenburg M, Lindner SE, Breit B, Green DR, McMahon SB, Borner C, Gu W, Maurer U. Phosphorylation of Tip60 by GSK-3 determines the induction of PUMA and apoptosis by p53. Molecular Cell. 42: 584-96. PMID 21658600 DOI: 10.1016/J.Molcel.2011.03.033  0.754
2011 Sussman RT, Zhang XY, McMahon SB. Enzymatic assays for assessing histone deubiquitylation activity. Methods (San Diego, Calif.). 54: 339-47. PMID 21513801 DOI: 10.1016/J.Ymeth.2011.04.001  0.39
2011 Mellert HS, Stanek TJ, Sykes SM, Rauscher FJ, Schultz DC, McMahon SB. Deacetylation of the DNA-binding domain regulates p53-mediated apoptosis. The Journal of Biological Chemistry. 286: 4264-70. PMID 21148320 DOI: 10.1074/Jbc.M110.184663  0.811
2011 La Rocca G, Shi B, Audia A, Ferrari-Amorotti G, Mellert HS, Calabretta B, McMahon SB, Sepp-Lorenzino L, Baserga R. Regulation of microRNA-145 by growth arrest and differentiation. Experimental Cell Research. 317: 488-95. PMID 21111732 DOI: 10.1016/J.Yexcr.2010.11.010  0.685
2010 Van Dang C, McMahon SB. Emerging Concepts in the Analysis of Transcriptional Targets of the MYC Oncoprotein: Are the Targets Targetable? Genes & Cancer. 1: 560-567. PMID 21533016 DOI: 10.1177/1947601910379011  0.44
2010 Aggarwal P, Vaites LP, Kim JK, Mellert H, Gurung B, Nakagawa H, Herlyn M, Hua X, Rustgi AK, McMahon SB, Diehl JA. Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase. Cancer Cell. 18: 329-40. PMID 20951943 DOI: 10.1016/J.Ccr.2010.08.012  0.735
2010 Norvell A, McMahon SB. Cell biology. Rise of the rival. Science (New York, N.Y.). 327: 964-5. PMID 20167774 DOI: 10.1126/Science.1187159  0.41
2009 Mellert HS, McMahon SB. hMOF, a KAT(8) with many lives. Molecular Cell. 36: 174-5. PMID 19854127 DOI: 10.1016/J.Molcel.2009.10.005  0.691
2009 Mellert HS, McMahon SB. Biochemical pathways that regulate acetyltransferase and deacetylase activity in mammalian cells. Trends in Biochemical Sciences. 34: 571-8. PMID 19819149 DOI: 10.1016/J.Tibs.2009.06.010  0.736
2009 Sykes SM, Stanek TJ, Frank A, Murphy ME, McMahon SB. Acetylation of the DNA binding domain regulates transcription-independent apoptosis by p53. The Journal of Biological Chemistry. 284: 20197-205. PMID 19494119 DOI: 10.1074/Jbc.M109.026096  0.747
2008 Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, Nissim I, Daikhin E, Yudkoff M, McMahon SB, Thompson CB. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proceedings of the National Academy of Sciences of the United States of America. 105: 18782-7. PMID 19033189 DOI: 10.1073/Pnas.0810199105  0.395
2008 Pietsch EC, Sykes SM, McMahon SB, Murphy ME. The p53 family and programmed cell death. Oncogene. 27: 6507-21. PMID 18955976 DOI: 10.1038/Onc.2008.315  0.699
2008 Zhang XY, Pfeiffer HK, Thorne AW, McMahon SB. USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A. Cell Cycle (Georgetown, Tex.). 7: 1522-4. PMID 18469533 DOI: 10.4161/Cc.7.11.5962  0.462
2008 Zhang XY, Varthi M, Sykes SM, Phillips C, Warzecha C, Zhu W, Wyce A, Thorne AW, Berger SL, McMahon SB. The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression. Molecular Cell. 29: 102-11. PMID 18206973 DOI: 10.1016/J.Molcel.2007.12.015  0.695
2008 McMahon SB. Control of nucleotide biosynthesis by the MYC oncoprotein: Old friends get reacquainted Cell Cycle. 7: 2276-2277. DOI: 10.4161/Cc.6648  0.485
2007 Mellert H, Sykes SM, Murphy ME, McMahon SB. The ARF/oncogene pathway activates p53 acetylation within the DNA binding domain. Cell Cycle (Georgetown, Tex.). 6: 1304-6. PMID 17534149 DOI: 10.4161/Cc.6.11.4343  0.785
2007 Patel JH, McMahon SB. BCL2 is a downstream effector of MIZ-1 essential for blocking c-MYC-induced apoptosis. The Journal of Biological Chemistry. 282: 5-13. PMID 17082179 DOI: 10.1074/Jbc.M609138200  0.784
2006 Sykes SM, Mellert HS, Holbert MA, Li K, Marmorstein R, Lane WS, McMahon SB. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Molecular Cell. 24: 841-51. PMID 17189187 DOI: 10.1016/J.Molcel.2006.11.026  0.802
2006 Chau CM, Zhang XY, McMahon SB, Lieberman PM. Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF. Journal of Virology. 80: 5723-32. PMID 16731911 DOI: 10.1128/Jvi.00025-06  0.381
2006 Knoepfler PS, Zhang XY, Cheng PF, Gafken PR, McMahon SB, Eisenman RN. Myc influences global chromatin structure. The Embo Journal. 25: 2723-34. PMID 16724113 DOI: 10.1038/Sj.Emboj.7601152  0.468
2006 Zhang XY, DeSalle LM, McMahon SB. Identification of novel targets of MYC whose transcription requires the essential MbII domain. Cell Cycle (Georgetown, Tex.). 5: 238-41. PMID 16434883 DOI: 10.4161/Cc.5.3.2409  0.486
2006 Patel JH, McMahon SB. Targeting of Miz-1 is essential for Myc-mediated apoptosis. The Journal of Biological Chemistry. 281: 3283-9. PMID 16352593 DOI: 10.1074/Jbc.M513038200  0.785
2005 Zhang XY, DeSalle LM, Patel JH, Capobianco AJ, Yu D, Thomas-Tikhonenko A, McMahon SB. Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. Proceedings of the National Academy of Sciences of the United States of America. 102: 13968-73. PMID 16172399 DOI: 10.1073/Pnas.0502330102  0.777
2004 Patel JH, Du Y, Ard PG, Phillips C, Carella B, Chen CJ, Rakowski C, Chatterjee C, Lieberman PM, Lane WS, Blobel GA, McMahon SB. The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60. Molecular and Cellular Biology. 24: 10826-34. PMID 15572685 DOI: 10.1128/Mcb.24.24.10826-10834.2004  0.768
2004 Patel JH, Loboda AP, Showe MK, Showe LC, McMahon SB. Analysis of genomic targets reveals complex functions of MYC. Nature Reviews. Cancer. 4: 562-8. PMID 15229481 DOI: 10.1038/Nrc1393  0.775
2002 Ard PG, Chatterjee C, Kunjibettu S, Adside LR, Gralinski LE, McMahon SB. Transcriptional regulation of the mdm2 oncogene by p53 requires TRRAP acetyltransferase complexes. Molecular and Cellular Biology. 22: 5650-61. PMID 12138177 DOI: 10.1128/Mcb.22.16.5650-5661.2002  0.529
2002 Nikiforov MA, Chandriani S, Park J, Kotenko I, Matheos D, Johnsson A, McMahon SB, Cole MD. TRRAP-dependent and TRRAP-independent transcriptional activation by Myc family oncoproteins. Molecular and Cellular Biology. 22: 5054-63. PMID 12077335 DOI: 10.1128/Mcb.22.14.5054-5063.2002  0.434
2002 Vieyra D, Loewith R, Scott M, Bonnefin P, Boisvert FM, Cheema P, Pastyryeva S, Meijer M, Johnston RN, Bazett-Jones DP, McMahon S, Cole MD, Young D, Riabowol K. Human ING1 proteins differentially regulate histone acetylation. The Journal of Biological Chemistry. 277: 29832-9. PMID 12015309 DOI: 10.1074/Jbc.M200197200  0.475
2002 Yanagisawa J, Kitagawa H, Yanagida M, Wada O, Ogawa S, Nakagomi M, Oishi H, Yamamoto Y, Nagasawa H, McMahon SB, Cole MD, Tora L, Takahashi N, Kato S. Nuclear receptor function requires a TFTC-type histone acetyl transferase complex. Molecular Cell. 9: 553-62. PMID 11931763 DOI: 10.1016/S1097-2765(02)00478-1  0.343
2001 Park J, Kunjibettu S, McMahon SB, Cole MD. The ATM-related domain of TRRAP is required for histone acetyltransferase recruitment and Myc-dependent oncogenesis. Genes & Development. 15: 1619-24. PMID 11445536 DOI: 10.1101/Gad.900101  0.391
2001 Lang SE, McMahon SB, Cole MD, Hearing P. E2F transcriptional activation requires TRRAP and GCN5 cofactors. The Journal of Biological Chemistry. 276: 32627-34. PMID 11418595 DOI: 10.1074/jbc.M102067200  0.353
2000 Wood MA, McMahon SB, Cole MD. An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc. Molecular Cell. 5: 321-30. PMID 10882073 DOI: 10.1016/S1097-2765(00)80427-X  0.438
2000 McMahon SB, Wood MA, Cole MD. The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Molecular and Cellular Biology. 20: 556-62. PMID 10611234 DOI: 10.1128/Mcb.20.2.556-562.2000  0.458
1999 Cole MD, McMahon SB. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene. 18: 2916-24. PMID 10378688 DOI: 10.1038/Sj.Onc.1202748  0.314
1998 McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD, Cole MD. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell. 94: 363-74. PMID 9708738 DOI: 10.1016/S0092-8674(00)81479-8  0.445
1990 Seyfert VL, McMahon SB, Glenn WD, Yellen AJ, Sukhatme VP, Cao XM, Monroe JG. Methylation of an immediate-early inducible gene as a mechanism for B cell tolerance induction. Science (New York, N.Y.). 250: 797-800. PMID 2237429 DOI: 10.1126/Science.2237429  0.337
Show low-probability matches.